Taku Ikenogami

Discovery of a novel azetidine scaffold for colony stimulating factor-1 receptor (CSF-1R) Type II inhibitors by the use of docking models.

Hiromasa Hashimoto, T. Yamasaki, T. Adachi, 2019, Bioorganic & medicinal chemistry letters.

Optimization of an azetidine series as inhibitors of colony stimulating factor-1 receptor (CSF-1R) Type II to lead to the clinical candidate JTE-952.

Hiromasa Hashimoto, T. Yamasaki, Kazutaka Ikegashira, 2019, Bioorganic & medicinal chemistry letters.

Discovery of a potent and short-acting oral calcilytic with a pulsatile secretion of parathyroid hormone.

K. Fukuda, Hiromasa Hashimoto, Teruhiko Inoue, 2011, ACS medicinal chemistry letters.

Discovery of Second Generation RORγ Inhibitors Composed of an Azole Scaffold.

Takayoshi Suzuki, Hiromasa Hashimoto, Makoto Shiozaki, 2019, Journal of medicinal chemistry.

Stereoselective synthesis of C-4′-aminouridines (uracil C-4-amino-D-ribonucleosides)

H. Togo, Taku Ikenogami, M. Yokoyama, 2000 .